138 related articles for article (PubMed ID: 25266473)
1. Effectiveness of humor intervention for patients with schizophrenia: a randomized controlled trial.
Cai C; Yu L; Rong L; Zhong H
J Psychiatr Res; 2014 Dec; 59():174-8. PubMed ID: 25266473
[TBL] [Abstract][Full Text] [Related]
2. Effects of humor and laughter on psychological functioning, quality of life, health status, and pulmonary functioning among patients with chronic obstructive pulmonary disease: a preliminary investigation.
Lebowitz KR; Suh S; Diaz PT; Emery CF
Heart Lung; 2011; 40(4):310-9. PubMed ID: 21724041
[TBL] [Abstract][Full Text] [Related]
3. Sense of humor in patients with schizophrenia.
Falkenberg I; Klügel K; Bartels M; Wild B
Schizophr Res; 2007 Sep; 95(1-3):259-61. PubMed ID: 17628438
[No Abstract] [Full Text] [Related]
4. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
[TBL] [Abstract][Full Text] [Related]
5. [Sense of humour in schizophrenia--ability of humour reception and possibilities of its application in therapeutic interventions].
Parnowska D; Braniecka A; Radomska A
Psychiatr Pol; 2013; 47(5):945-56. PubMed ID: 25011239
[TBL] [Abstract][Full Text] [Related]
6. Effect of self-consistency group intervention for adolescents with schizophrenia: An inpatient randomized controlled trial.
She P; Zeng H; Yang B
J Psychiatr Res; 2016 Feb; 73():63-70. PubMed ID: 26688437
[TBL] [Abstract][Full Text] [Related]
7. The effect of humorous movies on inpatients with chronic schizophrenia.
Gelkopf M; Gonen B; Kurs R; Melamed Y; Bleich A
J Nerv Ment Dis; 2006 Nov; 194(11):880-3. PubMed ID: 17102716
[TBL] [Abstract][Full Text] [Related]
8. Humor.
Woodbury-Fariña MA; Antongiorgi JL
Psychiatr Clin North Am; 2014 Dec; 37(4):561-78. PubMed ID: 25455066
[TBL] [Abstract][Full Text] [Related]
9. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
[TBL] [Abstract][Full Text] [Related]
10. Diminished humour perception in schizophrenia: relationship to social and cognitive functioning.
Polimeni JO; Campbell DW; Gill D; Sawatzky BL; Reiss JP
J Psychiatr Res; 2010 May; 44(7):434-40. PubMed ID: 19892368
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and feasibility of a humor training for people suffering from depression, anxiety, and adjustment disorder: a randomized controlled trial.
Tagalidou N; Distlberger E; Loderer V; Laireiter AR
BMC Psychiatry; 2019 Mar; 19(1):93. PubMed ID: 30894148
[TBL] [Abstract][Full Text] [Related]
12. A virtual reality-integrated program for improving social skills in patients with schizophrenia: a pilot study.
Rus-Calafell M; Gutiérrez-Maldonado J; Ribas-Sabaté J
J Behav Ther Exp Psychiatry; 2014 Mar; 45(1):81-9. PubMed ID: 24063993
[TBL] [Abstract][Full Text] [Related]
13. Laughter in a psychiatric ward. Somatic, emotional, social, and clinical influences on schizophrenic patients.
Gelkopf M; Kreitler S; Sigal M
J Nerv Ment Dis; 1993 May; 181(5):283-9. PubMed ID: 8501443
[TBL] [Abstract][Full Text] [Related]
14. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a standardized humor group in a clinical setting: a feasibility study for older patients with depression.
Konradt B; Hirsch RD; Jonitz MF; Junglas K
Int J Geriatr Psychiatry; 2013 Aug; 28(8):850-7. PubMed ID: 23132732
[TBL] [Abstract][Full Text] [Related]
16. The effects of humor therapy on nursing home residents measured using observational methods: the SMILE cluster randomized trial.
Low LF; Goodenough B; Fletcher J; Xu K; Casey AN; Chenoweth L; Fleming R; Spitzer P; Bell JP; Brodaty H
J Am Med Dir Assoc; 2014 Aug; 15(8):564-9. PubMed ID: 24814320
[TBL] [Abstract][Full Text] [Related]
17. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
18. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
19. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
20. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
